Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Wei Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7885-4378; OpenAlex author ID A5032495047. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 3

  1. HNRNPC regulates RhoA to induce DNA damage repair and cancer-associated fibroblast activation causing radiation resistance in pancreatic cancer. Co-author DOI 10.1111/jcmm.17254↗
  2. Theranostic nanoparticles enabling the release of phosphorylated gemcitabine for advanced pancreatic cancer therapy. Co-author DOI 10.1039/d0tb00017e↗
  3. Preliminary application of 3D-printed coplanar template for iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. Co-author DOI 10.3748/wjg.v24.i46.5280↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongmin Wang · 2 shared papers, 2018–2020 · strength 0.19
  2. Xiaoyi Ding · 2 shared papers, 2018–2020 · strength 0.19
  3. Ning Xia · 1 shared paper, 2022 · strength 0.16
  4. Xiaoyu Liu · 1 shared paper, 2022 · strength 0.16
  5. Zhongmin Wang · 1 shared paper, 2022 · strength 0.16
  6. Nannan Yang · 1 shared paper, 2022 · strength 0.16
  7. Fuyou Li · 1 shared paper, 2020 · strength 0.11
  8. Tao Sun · 1 shared paper, 2020 · strength 0.11
  9. Qingbing Wang · 1 shared paper, 2020 · strength 0.11
  10. Chen Jiang · 1 shared paper, 2020 · strength 0.11
  11. Jingjing Liu · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.